BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 34936030)

  • 1. TRP channel expression correlates with the epithelial-mesenchymal transition and high-risk endometrial carcinoma.
    Van den Eynde C; De Clercq K; Van Bree R; Luyten K; Annibali D; Amant F; Han S; Van Nieuwenhuysen E; Baert T; Peeraer K; Voets T; Van Gorp T; Vriens J
    Cell Mol Life Sci; 2021 Dec; 79(1):26. PubMed ID: 34936030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional expression of transient receptor potential channels in human endometrial stromal cells during the luteal phase of the menstrual cycle.
    De Clercq K; Held K; Van Bree R; Meuleman C; Peeraer K; Tomassetti C; Voets T; D'Hooghe T; Vriens J
    Hum Reprod; 2015 Jun; 30(6):1421-36. PubMed ID: 25820697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The functional expression of transient receptor potential channels in the mouse endometrium.
    De Clercq K; Van den Eynde C; Hennes A; Van Bree R; Voets T; Vriens J
    Hum Reprod; 2017 Mar; 32(3):615-630. PubMed ID: 28077439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-194 inhibits epithelial to mesenchymal transition of endometrial cancer cells by targeting oncogene BMI-1.
    Dong P; Kaneuchi M; Watari H; Hamada J; Sudo S; Ju J; Sakuragi N
    Mol Cancer; 2011 Aug; 10():99. PubMed ID: 21851624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-106b modulates epithelial-mesenchymal transition by targeting TWIST1 in invasive endometrial cancer cell lines.
    Dong P; Kaneuchi M; Watari H; Sudo S; Sakuragi N
    Mol Carcinog; 2014 May; 53(5):349-59. PubMed ID: 24002805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transient Receptor Potential Channels in the Epithelial-to-Mesenchymal Transition.
    Van den Eynde C; De Clercq K; Vriens J
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular profiling of circulating tumor cells links plasticity to the metastatic process in endometrial cancer.
    Alonso-Alconada L; Muinelo-Romay L; Madissoo K; Diaz-Lopez A; Krakstad C; Trovik J; Wik E; Hapangama D; Coenegrachts L; Cano A; Gil-Moreno A; Chiva L; Cueva J; Vieito M; Ortega E; Mariscal J; Colas E; Castellvi J; Cusido M; Dolcet X; Nijman HW; Bosse T; Green JA; Romano A; Reventos J; Lopez-Lopez R; Salvesen HB; Amant F; Matias-Guiu X; Moreno-Bueno G; Abal M;
    Mol Cancer; 2014 Sep; 13():223. PubMed ID: 25261936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TMEFF2 is a novel prognosis signature and target for endometrial carcinoma.
    Gao L; Nie X; Zheng M; Li X; Guo Q; Liu J; Liu Q; Hao Y; Lin B
    Life Sci; 2020 Feb; 243():116910. PubMed ID: 31610211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kruppel-like factor 4 (KLF-4) inhibits the epithelial-to-mesenchymal transition and proliferation of human endometrial carcinoma cells.
    Wang X; Li X; Huang C; Li L; Qu H; Yu X; Ni H; Cui Q
    Gynecol Endocrinol; 2016 Sep; 32(9):772-776. PubMed ID: 27098518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiR-195 inhibits migration, invasion and epithelial-mesenchymal transition (EMT) of endometrial carcinoma cells by targeting SOX4.
    Zhao X; Dai L; Yue Q; Wang H; Wang XU; Li Y; Chen R
    J Biosci; 2019 Dec; 44(6):. PubMed ID: 31894127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer-Associated Fibroblasts Induce Epithelial-Mesenchymal Transition in Endometrial Cancer Cells by Regulating Pituitary Tumor Transforming Gene.
    Wang X; Sun X; Mu L; Chen W
    Cancer Invest; 2019; 37(3):134-143. PubMed ID: 30961403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reactivation of epigenetically silenced miR-124 reverses the epithelial-to-mesenchymal transition and inhibits invasion in endometrial cancer cells via the direct repression of IQGAP1 expression.
    Dong P; Ihira K; Xiong Y; Watari H; Hanley SJ; Yamada T; Hosaka M; Kudo M; Yue J; Sakuragi N
    Oncotarget; 2016 Apr; 7(15):20260-70. PubMed ID: 26934121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ETV5 transcription program links BDNF and promotion of EMT at invasive front of endometrial carcinomas.
    Alonso-Alconada L; Eritja N; Muinelo-Romay L; Barbazan J; Lopez-Lopez R; Matias-Guiu X; Gil-Moreno A; Dolcet X; Abal M
    Carcinogenesis; 2014 Dec; 35(12):2679-86. PubMed ID: 25233929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. eIF4E‑related miR‑320a and miR‑340‑5p inhibit endometrial carcinoma cell metastatic capability by preventing TGF‑β1‑induced epithelial‑mesenchymal transition.
    Zhang HH; Li R; Li YJ; Yu XX; Sun QN; Li AY; Kong Y
    Oncol Rep; 2020 Feb; 43(2):447-460. PubMed ID: 31894279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TESTIN was commonly hypermethylated and involved in the epithelial-mesenchymal transition of endometrial cancer.
    Dong R; Pu H; Wang Y; Yu J; Lian K; Mao C
    APMIS; 2015 May; 123(5):394-400. PubMed ID: 25720371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disrupting MALAT1/miR-200c sponge decreases invasion and migration in endometrioid endometrial carcinoma.
    Li Q; Zhang C; Chen R; Xiong H; Qiu F; Liu S; Zhang M; Wang F; Wang Y; Zhou X; Xiao G; Wang X; Jiang Q
    Cancer Lett; 2016 Dec; 383(1):28-40. PubMed ID: 27693631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional Expression of TRP Ion Channels in Endometrial Stromal Cells of Endometriosis Patients.
    Persoons E; Hennes A; De Clercq K; Van Bree R; Vriens G; O DF; Peterse D; Vanhie A; Meuleman C; Voets T; Tomassetti C; Vriens J
    Int J Mol Sci; 2018 Aug; 19(9):. PubMed ID: 30134548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteomic Characterization of Epithelial-Like Extracellular Vesicles in Advanced Endometrial Cancer.
    Mariscal J; Fernandez-Puente P; Calamia V; Abalo A; Santacana M; Matias-Guiu X; Lopez-Lopez R; Gil-Moreno A; Alonso-Alconada L; Abal M
    J Proteome Res; 2019 Mar; 18(3):1043-1053. PubMed ID: 30585730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of the epithelial-mesenchymal transition by SHARP1 is linked to the NOTCH1 signaling pathway in metastasis of endometrial cancer.
    Liao Y; He X; Qiu H; Che Q; Wang F; Lu W; Chen Z; Qiu M; Wang J; Wang H; Wan X
    BMC Cancer; 2014 Jul; 14():487. PubMed ID: 24997474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eribulin mesilate suppresses experimental metastasis of breast cancer cells by reversing phenotype from epithelial-mesenchymal transition (EMT) to mesenchymal-epithelial transition (MET) states.
    Yoshida T; Ozawa Y; Kimura T; Sato Y; Kuznetsov G; Xu S; Uesugi M; Agoulnik S; Taylor N; Funahashi Y; Matsui J
    Br J Cancer; 2014 Mar; 110(6):1497-505. PubMed ID: 24569463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.